Prostate cancer progression has been linked to high-level expression of lipid metabolism genes (e.g., OLR1, GLRX and SNAP23) which could contribute to the dysregulation of lipid distribution in the tumor cell membrane [36]. The gene discussed is OLR1; the disease is prostate carcinoma.